Efficacy and Safety Study of a Percussion Device to Mobilise Sputum From Respiratory Passage (LEGA)

December 4, 2012 updated by: Dr.Ong Loke Meng, Penang Hospital, Malaysia

"A Prospective, Cross-over Randomized Trial to Assess the Efficacy and Safety of Mechanical Percussor "LEGA" Compared With Conventional Chest Physiotherapy in Adults With Chronic Bronchiectasis or Chronic Obstructive Pulmonary Disease (COPD

A Malaysian company by name Formedic Technologies SDN BHD has devised a hand held machine which is supposed to mimic the chest percussion performed by professional physiotherapist to mobilize sputum through the respiratory passage.

The aim of this study is to compare the effectiveness and safety of this mechanical percussion device in the treatment of airway clearance with conventional chest physiotherapy carried out by qualified physiotherapists in patients suffering from bronchiectasis or Chronic obstructive Pulmonary disease (COPD).

Study Overview

Detailed Description

This study will compare the amount of sputum expectorated during the two procedures and not intended to look at the clinical improvement of the patient.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Phase 2
  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Penang
      • George Town, Penang, Malaysia, 10990
        • Penang Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Adult patients > 18 years of age
  2. Chronic sputum expectoration-(producing >30ml/day of sputum at baseline)
  3. Clinical diagnosis of bronchiectasis or COPD
  4. Not carrying out regular chest physiotherapy (for the purposes of this study this will be defined as less than two occasions per week)
  5. Clinically stable disease (defined as no requirement for antibiotics in the 4 weeks preceding study entry).
  6. FEV1 of > 35% of the predicted value in COPD patients

Exclusion Criteria:

  1. Primary diagnosis of asthma;
  2. Active sarcoidosis
  3. Active Pulmonary tuberculosis.
  4. History of brittle bones,
  5. History of broken ribs in the past one year.
  6. History of severe osteoporosis
  7. Bleeding from the lungs or haemoptysis
  8. Experiencing intense pain in the thoracic region
  9. Clinical suspicion of increased intracranial pressure.
  10. Have head or neck injuries
  11. Have collapsed lungs or a damaged chest wall;
  12. Recent myocardial infarction, unstable angina and stroke (Within 6 months prior to enrollment)
  13. Have a pulmonary embolism or lung abscess;
  14. Have an active hemorrhage
  15. Have injuries to the spine
  16. Have open wounds or burns in the thoracic region
  17. Have had recent surgery (Within six months prior to enrollment.)
  18. Any systemic steroids within 4/52 prior to enrollment
  19. Any antibiotics within 4/52 prior to enrollment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Conventional Chest PhysioTherapy
Conventional Chest Physiotherapy (CCPT) is delivered by professional physiotherapist for 15 minutes.
Conventional chest percussion will be applied for a duration of 15 minutes.
Other Names:
  • Manual percussion
Experimental: Mechanical percussion
Mechanical percussion will be delivered by a device called "LEGA" for 15 minutes
Mechanical chest percussion will be delivered by a device for 15 minutes.
Other Names:
  • LEGA

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparing the 'wet weight' and 'dry weight' of the sputum expectorated during 20 minutes of the two procedures.
Time Frame: 6 days
The patients will be instructed to cough out the sputum into a preweighed container during the 15 minutes of the procedure(Manual or mechanical percussion)and 5 minutes after the procedure.Container will be weighed to get the wet weight of the sputum then will be dried in a laboratory oven at 60degree c for 48 hours and weighed again to get the dry weight of the sputum
6 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in FEV1 and FVC before and after the two methods of therapy
Time Frame: 15 minutes after completion of the procedure compared to baseline
Any changes in the lung function will be measured as - FEV1 (%predicted) and FVC (%predicted)
15 minutes after completion of the procedure compared to baseline
Changes in pulse, blood pressure and respiratory rate
Time Frame: 15 minutes after completion of treatment compared to baseline
Monitoring of Pulse, blood pressure, respiratory rate, skin colour and patients reaction to treatment.
15 minutes after completion of treatment compared to baseline
Patient preference
Time Frame: After completing 6 days of participation in the study
Patients will be participating in the study for 6 days. On the 6th day after completion of treatment they will be required to answer a simple questionnaire to find out if they prefer one procedure over the other and why.
After completing 6 days of participation in the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ong L Meng, MBBS, FRCP, Penang Hospital, Malaysia
  • Principal Investigator: Mohd I Izmi, MBBS, MD, Penang Hospital, Malaysia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2011

Primary Completion (Actual)

June 1, 2012

Study Completion (Actual)

June 1, 2012

Study Registration Dates

First Submitted

November 20, 2011

First Submitted That Met QC Criteria

November 24, 2011

First Posted (Estimate)

November 29, 2011

Study Record Updates

Last Update Posted (Estimate)

December 6, 2012

Last Update Submitted That Met QC Criteria

December 4, 2012

Last Verified

December 1, 2012

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD)

Clinical Trials on Conventional Chest Physiotherapy (CCPT)

Subscribe